Biogen, UCB Present Positive Phase 3 Results for Lupus Drug Candidate at EULAR 2025
Biogen Inc. (NASDAQ:BIIB) is one of the 11 most profitable NASDAQ stocks to buy now.
Biogen Inc. (BIIB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | D E Shaw D. E. Shaw | 1,585,572 | $216,969,673 | -2% | 0.19% |
| 2. | AQR Capital Management Cliff Asness | 1,368,842 | $187,257,678 | +154% | 0.19% |
| 3. | 998,400 | $136,621,056 | +319% | 0.03% | |
| 4. | Renaissance Technologies Jim Simons | 804,506 | $110,088,601 | -33% | 0.17% |
| 5. | Balyasny Asset Management Dmitry Balyasny | 786,219 | $107,586,208 | +1616% | 0.18% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $122.72 | 1,235 | Director | 27,842 | 2025-05-02 | Filing | |
| $222.54 | 455 | Director | 20,629 | 2024-02-15 | Filing | |
| $267.00 | 898 | Director | 2,943 | 2021-02-09 | Filing | |
| $241.31 | 3,100 | Officer, Director | 34,810 | 2020-11-30 | Filing | |
| $231.24 | 38,000 | Director | 643,000 | 2019-05-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $126.25 | 3,806 | Officer | 5,427 | 2025-05-19 | Filing | |
| $150.02 | 8,760 | Director | 11,318 | 2025-03-07 | Filing | |
| $157.21 | 110 | Officer | 5,426 | 2024-12-09 | Filing | |
| $204.22 | 431 | Officer | 5,316 | 2024-09-03 | Filing | |
| $213.09 | 93 | Officer | 4,886 | 2024-04-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 17,032,839 | $2,330,773,689 | 0.04% | |
| 2. | 15,943,259 | $2,181,675,561 | 1.8% | |
| 3. | 15,211,036 | $2,081,478,238 | 0.04% | |
| 4. | 7,396,910 | $1,012,193,164 | 0.04% | |
| 5. | 4,672,437 | $639,376,280 | 0.12% |
News See All
11 Most Profitable NASDAQ Stocks to Buy Now
Earlier on May 30, Siebert Financial CIO Mark Malek appeared on CNBC to discuss the tariff headwinds swirling around the markets and which sectors could then rise above the noise and continue to perform...
15 Best Stocks to Invest in for an 18 Year Old
The Bureau of Labor Statistics stated on June 11 that consumer prices increased less than anticipated in May given that President Donald Trump's tariffs had not yet had a noticeable effect on inflation...
Biogen Inc. (BIIB) Taps RNAi Therapy in City Therapeutics Deal
Biogen Inc. (NASDAQ:BIIB)’s recent partnership with City Therapeutics, Inc.
15 Small-Cap Healthcare Stocks Hedge Funds Are Buying
The U.S. healthcare sector has performed better in 2025 compared to the broader market. After two years of weak performance, the healthcare sector kicked off on a strong note in 2025.
Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
Biogen Inc. (NASDAQ:BIIB) Q1 2025 Earnings Call Transcript
Operator: Good morning. My name is Melinda, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Biogen First Quarter 2025 Earnings Call and Business Update.
7 Most Undervalued Biotech Stocks To Invest In
On February 21, Jared Holz, Mizuho Securities America's healthcare sector strategist, appeared on CNBC to discuss Trump's tariffs and their effects on the American pharma sector.
15 Stocks That Will Go to The Moon According to Analysts
While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President delayed tariffs on Mexico...
10 Cheap Pharmaceutical Stocks to Buy According to Analysts
Almost no other industry goes as far as the phrase "defensive" as the healthcare sector, which encompasses a wide range of companies that provide patient care, research and development of new medicines...
Billionaire Hedge Funds
